Clinical Trials Logo

Esophagitis clinical trials

View clinical trials related to Esophagitis.

Filter by:

NCT ID: NCT01929824 Completed - Clinical trials for Eosinophilic Esophagitis

Nasal Nitric Oxide Levels in Eosinophilic Esophagitis (EoE)

Start date: August 2013
Phase:
Study type: Observational

This study is aimed at understanding whether oral nitric oxide levels can be used as a non-invasive marker for the diagnosis and management of patient with eosinophilic esophagitis (EoE).

NCT ID: NCT01921686 Active, not recruiting - Clinical trials for Gastroesophageal Reflux Disease

Morphological Markers of Gastroesophageal Reflux Disease (GERD)

Start date: March 2013
Phase:
Study type: Observational

The purpose of this project is to learn more about a new and promising way to diagnose acid reflux disease using a very high-powered microscope. This special microscope provides much finer detail than typical microscopes previously used for diagnosing reflux, and may help doctors to better identify children with acid reflux.

NCT ID: NCT01897506 Completed - Asthma Clinical Trials

Assessing Risk of Food Insecurity Within Households of Children With Food Allergy

Start date: June 2013
Phase:
Study type: Observational

Our central hypothesis is that dietary limitations introduced by food allergy will contribute to increased food insecurity in households with food allergic children when compared to food insecure households without food allergic children.

NCT ID: NCT01874535 Completed - Erosive Esophagitis Clinical Trials

Rate of Complete Symptom Relief, Prevention of Symptom Relapse: Grades A and B Esophagitis of Esomeprazole Therapy

Start date: June 2010
Phase: Phase 4
Study type: Interventional

To investigate the impact of initial treatment duration (4-week versus 8-week)of Esomeprazole (40mg) on the rate of symptom relapse and sustained healing of esophagitis in patients with symptomatic erosive esophagitis

NCT ID: NCT01865825 Completed - Erosive Esophagitis Clinical Trials

Proton Pump Inhibitor (PPI) Responsive Eosinophilic Esophagitis EoE: Gastroesophageal Reflux Disease (GERD) or Eosinophilic Esophagitis (EoE)?

Start date: March 2013
Phase: N/A
Study type: Observational

The investigators would like to determine if there are patients with PPI responsive Eosinophilic Esophagitis Infiltration that have significant loss of esophageal distensibility suggestive of esophageal fibrosis typical of classic Eosniophilic Esophagitis. If this group of patients exists, the investigators would like to determine if they have the typical endoscopic features of EoE rather than those of GERD.

NCT ID: NCT01860482 Completed - Reflux Esophagitis Clinical Trials

The Study to Evaluate Efficacy and Safety of Newrabell® Tab.(Rabeprazole Sodium) 10mg b.i.d in Refractory GERD

Start date: April 2013
Phase: Phase 4
Study type: Interventional

The purpose of this study is to assess the efficacy and safety of Newrabell® Tab. in patients with refractory reflux esophagitis to the prior standard PPIs regimen.

NCT ID: NCT01846962 Completed - Clinical trials for Eosinophilic Esophagitis

Dietetic Versus Topical Steroids for Pediatric Eosinophilic Esophagitis

Start date: November 2012
Phase: Phase 4
Study type: Interventional

Therapeutic strategies for eosinophilic esophagitis (EoE) actually include: 1) allergen avoidance through dietary modifications, and 2) pharmacologic antiinflammatory therapy. Medical treatment is mainly based on topical administration of corticosteroids by swallowing fluticasone propionate or budesonide spray. Dietetic treatment with highest efficacy is elemental diet, consisting in exclusive feeding with amino-acid based formulas, often administered trough SNG. Alternative choices of acceptable efficacy are empirical six-foods elimination diet (cow's milk, egg, soy, wheat, peanuts, fish) and targeted elimination diet based on the results of allergy tests. Most of the paediatric patients with EE respond to elemental or targeted elimination diets, and therefore such authors recommend elimination diets to be considered the treatment of choice in children. However, elimination diets can often be complex to follow and may be associated with poor adherence owing to the low palatability of a highly restricted diet. In non-compliant patients, especially in adolescents and young adults, it may be more practical to proceed first with corticosteroid treatment. In the case of partial response to elimination diets or corticosteroids, a combination of both treatment mod. However, there has been limited testing of these regimens in randomized controlled trials, while most of available literature is based on case series. The aim of this study was to compare the efficacy of six-foods elimination diet, swallowed fluticasone, swallowed budesonide and oral viscous budesonide (OVB) in pediatric patients with active EoE. The investigators assessed the effects of randomly assigned treatment on clinical and endoscopic/histologic severity as primary and secondary outcomes, respectively. The investigators describe clinical, allergological, endoscopic and histological features, and pH study results, of our pediatric population.

NCT ID: NCT01832324 Enrolling by invitation - Clinical trials for Eosinophilic Esophagitis

Molecular Basis of Food Allergy

Start date: January 2011
Phase:
Study type: Observational

The Study examines the molecular basis of food allergy. It explores the interaction between T cells, InKT cells and cytokines in the development of food allergy. The study also explores these factors in development of tolerance "outgrowing" food allergy. It will also explore the genetic factors that lead to the development of food allergy. The study examines all type of food allergy including IgE mediated reactions, Eosinophilic Esophagitis and Food Protein Induced Enterocolitis

NCT ID: NCT01824199 Withdrawn - Esophagitis Clinical Trials

CYP2C19 Genotype Predictor of Gastric Acid Suppression

Start date: March 2013
Phase: Early Phase 1
Study type: Interventional

If CYP2C19 genotype can predict the efficacy of healing erosive esophagitis and gastric acid secretion in patients taking once a day omeprazole.

NCT ID: NCT01821898 Terminated - Clinical trials for Eosinophilic Esophagitis

Eosinophilic Esophagitis Clinical Therapy Comparison Trial

Start date: July 9, 2013
Phase: Phase 2
Study type: Interventional

Eosinophilic Esophagitis (EoE) is a disorder in which a type of white blood cell (eosinophil) involved in allergic reactions, enter and cover the walls of the esophagus (food pipe). As a result, the esophagus becomes swollen and blocked making it difficult to swallow, and this leads to heartburn. In severe cases it can lead to food getting stuck in the esophagus and poor growth or weight loss in children The main purpose of this research study is to compare the effectiveness of two different types of treatment for EoE: 1. Oral viscous budesonide- which is a steroid medication that has been used to treat asthma. Recently, it has been used as a therapy to treat the eosinophilic inflammation in EoE, and 2. Specific food elimination. The study will also be looking to see if a blood test is useful in following the progression of EoE. Currently the only way to follow EoE is by repeating endoscopy, which is a more "invasive test."